Robeauté develops a neurosurgical microrobot intended to navigate brain tissue through a minimally invasive entry point for diagnosis, monitoring and local treatment. Founded in Paris in 2017, the company raised $28 million in 2025 to advance development and prepare for clinical translation.
Comparable profiles and adjacent companies connected by shared workflow, capability, or stack position.